M.D.C. (NYSE:MDC) Now Covered by Analysts at StockNews.com

StockNews.com initiated coverage on shares of M.D.C. (NYSE:MDC) in a report issued on Saturday. The firm set a “hold” rating on the construction company’s stock.

Other analysts have also recently issued research reports about the stock. Raymond James reissued a “market perform” rating on shares of M.D.C. in a report on Wednesday, February 7th. Evercore ISI cut shares of M.D.C. from an “outperform” rating to an “in-line” rating and lifted their target price for the company from $57.00 to $63.00 in a report on Wednesday, January 31st. One research analyst has rated the stock with a sell rating and five have issued a hold rating to the company. According to MarketBeat.com, M.D.C. currently has an average rating of “Hold” and a consensus target price of $52.13.

M.D.C. Stock Up 0.0 %

MDC stock opened at $62.98 on Friday. The company has a current ratio of 9.76, a quick ratio of 3.92 and a debt-to-equity ratio of 0.50. M.D.C. has a twelve month low of $36.47 and a twelve month high of $63.00. The company’s 50 day moving average is $62.79 and its two-hundred day moving average is $54.83. The stock has a market cap of $4.73 billion, a P/E ratio of 11.93 and a beta of 1.54.

M.D.C. (NYSE:MDC) last released its quarterly earnings data on Tuesday, January 30th. The construction company reported $1.56 earnings per share for the quarter, topping analysts’ consensus estimates of $1.50 by $0.06. M.D.C. had a net margin of 8.64% and a return on equity of 12.32%. The company had revenue of $1.31 billion for the quarter, compared to analysts’ expectations of $1.29 billion. During the same quarter last year, the company earned $1.08 earnings per share. The firm’s revenue for the quarter was down 11.9% on a year-over-year basis. Research analysts expect that M.D.C. will post 5.7 earnings per share for the current fiscal year.

Insider Activity

In other M.D.C. news, Director David E. Blackford sold 6,200 shares of the business’s stock in a transaction on Monday, March 11th. The shares were sold at an average price of $62.69, for a total value of $388,678.00. Following the transaction, the director now directly owns 13,534 shares of the company’s stock, valued at approximately $848,446.46. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Corporate insiders own 23.30% of the company’s stock.

Hedge Funds Weigh In On M.D.C.

Several institutional investors have recently bought and sold shares of the company. Nilsine Partners LLC increased its stake in M.D.C. by 19.6% in the 1st quarter. Nilsine Partners LLC now owns 6,401 shares of the construction company’s stock valued at $403,000 after buying an additional 1,048 shares during the period. FCG Investment Co purchased a new stake in shares of M.D.C. during the 1st quarter worth $225,000. Monument Capital Management purchased a new stake in shares of M.D.C. during the 1st quarter worth $217,000. Hexagon Capital Partners LLC boosted its position in shares of M.D.C. by 102.0% during the 1st quarter. Hexagon Capital Partners LLC now owns 816 shares of the construction company’s stock worth $51,000 after purchasing an additional 412 shares in the last quarter. Finally, Hennion & Walsh Asset Management Inc. purchased a new stake in shares of M.D.C. during the 1st quarter worth $259,000. 88.08% of the stock is owned by institutional investors and hedge funds.

M.D.C. Company Profile

M.DC Holdings, Inc, through its subsidiaries, engages in the homebuilding and financial service businesses. Its homebuilding operations include purchasing finished lots or developing lots for the construction and sale primarily of single-family detached homes to first-time and first-time move-up homebuyers under the Richmond American Homes name.